You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

azd2281

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Worldwide (AZD2281)

Active, not recruiting
  • Solid Tumors
  • AZD2281
  • Randwick, Australia
  • +7 more
Dec 19, 2022

Solid Tumors Trial in Milano, Bellinzona, Chur (AZD2281, liposomal doxorubicin)

Active, not recruiting
  • Solid Tumors
  • AZD2281
  • liposomal doxorubicin
  • Milano, Italy
  • +2 more
Nov 17, 2021

Cancer Trial in United States (AZD2281, AZD5363, AZD1775)

Active, not recruiting
  • Cancer
  • AZD2281
  • +3 more
  • New Haven, Connecticut
  • +3 more
Sep 14, 2021

Ovarian Cancer Trial in Worldwide (AZD2281, matching )

Active, not recruiting
Has Results
  • Ovarian Cancer
  • AZD2281
  • matching placebo
  • Berkeley, California
  • +73 more
Dec 19, 2022

Ovarian Tumors Trial in Worldwide (AZD2281, Liposomal Doxorubicin)

Completed
Has Results
  • Ovarian Neoplasms
  • AZD2281
  • Liposomal Doxorubicin
  • Los Angeles, California
  • +23 more
Nov 12, 2019

Breast Cancer, Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (AZD2281, Paclitaxel)

Completed
  • Breast Cancer
  • +2 more
  • Auchenflower, Australia
  • +5 more
Mar 5, 2018

Tumor Metastasis Trial in Manchester, Oxford (AZD2281, Bevacizumab)

Completed
  • Neoplasm Metastasis
  • Manchester, United Kingdom
  • +1 more
Jan 13, 2015

Tumor Metastasis Trial in London (AZD2281)

Completed
  • Neoplasm Metastasis
  • AZD2281
  • London, United Kingdom
    Research Site
Jan 13, 2009